HI everyone, have just found an article on Yahoo health news that Taxol may only be affective on those with HER2 tumours and not oestrogen driven tumours. This is a bit worrying as I had my treatment 4 years ago and have been sticking 2 fingers up to it ever since. Did a zip slide for Marie Curie last week… Fantastic… But What do you think now. I’m not HER2 receptive and my tumour was only 10% oestrogen receptive, am I in the shit or what?
hi nirhikei,
interesting, I shall have to look at yahoo when i have time - visitors today 
My surgeon has said he expects my tumour to be HER -ve, my oncologist has me on the TAC chemo - after chemo 3 i’ll have another scan to measure the tumour. If this report is right then I’d expect the tumour to either be the same size or larger. I shall be interested to know.
On a positive note - any cells elsewhere that were thinking of becoming cancerous will have just had an almighty shock! Hopefully this will keep them quiet for another 50 years 
regards
ruth
Hi
This is very worrying. I suppose the results also apply to taxotere which is v. similar to taxol…i’m just about to start taxotere with an ER+ tumour…does anybody on this site have experience of an ER+ tumour shrinking with tax?
Jo
xx
Taxotere worked where FEC didn’t for me.
I have IBC and the tax worked on the lymphs under my arm.
Mabel
x
I’m very pleased it worked for you Mabel…That must have been a wonderful relief for you.
Jo
x
This is one to be careful about. The story was largely written for the US where almost all BC patients, including ones with the more usual ER+, her2- type, were routinely given three-weekly taxol on top of AC (adriamycin+cyclophosphamide) in the recent past. The message was that the only er-positive patients who seemed to benefit from taxol in this study are her2-positive ones. AC is rarely used in Britain, so the relevance of this study is somewhat limited for us.